FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3203883396> ?p ?o ?g. }

• W3203883396 endingPage "10798" @default.
• W3203883396 startingPage "10798" @default.
• W3203883396 abstract "Amyloid beta (Aβ) oligomers are the most neurotoxic aggregates causing neuronal death and cognitive damage. A detailed elucidation of the aggregation pathways from oligomers to fibril formation is crucial to develop therapeutic strategies for Alzheimer's disease (AD). Although experimental techniques rely on the measure of time- and space-average properties, they face severe difficulties in the investigation of Aβ peptide aggregation due to their intrinsically disorder character. Computer simulation is a tool that allows tracing the molecular motion of molecules; hence it complements Aβ experiments, as it allows to explore the binding mechanism between metal ions and Aβ oligomers close to the cellular membrane at the atomic resolution. In this context, integrated studies of experiments and computer simulations can assist in mapping the complete pathways of aggregation and toxicity of Aβ peptides. Aβ oligomers are disordered proteins, and due to a rapid exploration of their intrinsic conformational space in real-time, they are challenging therapeutic targets. Therefore, no good drug candidate could have been identified for clinical use. Our previous investigations identified two small molecules, M30 (2-Octahydroisoquinolin-2(1H)-ylethanamine) and Gabapentin, capable of Aβ binding and inhibiting molecular aggregation, synaptotoxicity, intracellular calcium signaling, cellular toxicity and memory losses induced by Aβ. Thus, we recommend these molecules as novel candidates to assist anti-AD drug discovery in the near future. This review discusses the most recent research investigations about the Aβ dynamics in water, close contact with cell membranes, and several therapeutic strategies to remove plaque formation." @default.
• W3203883396 created "2021-10-11" @default.
• W3203883396 creator A5006747824 @default.
• W3203883396 creator A5020312597 @default.
• W3203883396 creator A5074544353 @default.
• W3203883396 date "2021-10-06" @default.
• W3203883396 modified "2023-10-17" @default.
• W3203883396 title "An Overview of Several Inhibitors for Alzheimer’s Disease: Characterization and Failure" @default.
• W3203883396 cites W1580480113 @default.
• W3203883396 cites W1664338907 @default.
• W3203883396 cites W1890431460 @default.
• W3203883396 cites W1960543132 @default.
• W3203883396 cites W1965959381 @default.
• W3203883396 cites W1967549235 @default.
• W3203883396 cites W1968041782 @default.
• W3203883396 cites W1968790827 @default.
• W3203883396 cites W1971511188 @default.
• W3203883396 cites W1972535964 @default.
• W3203883396 cites W1973644268 @default.
• W3203883396 cites W1974156328 @default.
• W3203883396 cites W1976063693 @default.
• W3203883396 cites W1976846652 @default.
• W3203883396 cites W1977852800 @default.
• W3203883396 cites W1986623185 @default.
• W3203883396 cites W1989696614 @default.
• W3203883396 cites W1998750669 @default.
• W3203883396 cites W2003066171 @default.
• W3203883396 cites W2004319881 @default.
• W3203883396 cites W2005184232 @default.
• W3203883396 cites W2005914219 @default.
• W3203883396 cites W2006790475 @default.
• W3203883396 cites W2027636818 @default.
• W3203883396 cites W2028872675 @default.
• W3203883396 cites W2029151822 @default.
• W3203883396 cites W2030325989 @default.
• W3203883396 cites W2033451537 @default.
• W3203883396 cites W2035385837 @default.
• W3203883396 cites W2035613313 @default.
• W3203883396 cites W2037158866 @default.
• W3203883396 cites W2038980320 @default.
• W3203883396 cites W2050262214 @default.
• W3203883396 cites W2051147452 @default.
• W3203883396 cites W2051516838 @default.
• W3203883396 cites W2057871179 @default.
• W3203883396 cites W2059744863 @default.
• W3203883396 cites W2060757799 @default.
• W3203883396 cites W2069098917 @default.
• W3203883396 cites W2075537193 @default.
• W3203883396 cites W2081388499 @default.
• W3203883396 cites W2083500052 @default.
• W3203883396 cites W2090272323 @default.
• W3203883396 cites W2094808560 @default.
• W3203883396 cites W2095674336 @default.
• W3203883396 cites W2103440561 @default.
• W3203883396 cites W2104194752 @default.
• W3203883396 cites W2109956926 @default.
• W3203883396 cites W2111583366 @default.
• W3203883396 cites W2113950441 @default.
• W3203883396 cites W2114648545 @default.
• W3203883396 cites W2118280241 @default.
• W3203883396 cites W2121963977 @default.
• W3203883396 cites W2122294662 @default.
• W3203883396 cites W2126652410 @default.
• W3203883396 cites W2129489564 @default.
• W3203883396 cites W2133146732 @default.
• W3203883396 cites W2151747945 @default.
• W3203883396 cites W2153166022 @default.
• W3203883396 cites W2160557120 @default.
• W3203883396 cites W2166052084 @default.
• W3203883396 cites W2166427101 @default.
• W3203883396 cites W2256945054 @default.
• W3203883396 cites W2258663952 @default.
• W3203883396 cites W2296995867 @default.
• W3203883396 cites W2302067748 @default.
• W3203883396 cites W2313725855 @default.
• W3203883396 cites W2321195257 @default.
• W3203883396 cites W2321225818 @default.
• W3203883396 cites W2321856447 @default.
• W3203883396 cites W2322158256 @default.
• W3203883396 cites W2327000477 @default.
• W3203883396 cites W2401624005 @default.
• W3203883396 cites W2404280981 @default.
• W3203883396 cites W2413334978 @default.
• W3203883396 cites W2474799636 @default.
• W3203883396 cites W2486238113 @default.
• W3203883396 cites W2487730443 @default.
• W3203883396 cites W2502163229 @default.
• W3203883396 cites W2510806376 @default.
• W3203883396 cites W2519805918 @default.
• W3203883396 cites W2522173033 @default.
• W3203883396 cites W2551711394 @default.
• W3203883396 cites W2555870966 @default.
• W3203883396 cites W2580969766 @default.
• W3203883396 cites W2588157903 @default.
• W3203883396 cites W2600991905 @default.
• W3203883396 cites W2604285326 @default.
• W3203883396 cites W2606709392 @default.
• W3203883396 cites W2609476392 @default.

• next